Cervical cancer is a leading cause of mortality among women in developed countries, screening programmers have resulted in a substantial reduction of cervical cancer and burden of cervical cancer mortality in developed countries Objectives: To determine the abnormal rate and the valuation of VIA and Pap-smear in cervical cancer screening.